Cinqaero
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cinqaero, covering 2025-04-11 to 2025-04-11. Get the full timeline:
Most recent: EMA Authorised: Cinqaero (reslizumab) — Teva B.V.
1 regulatory and trial event tracked for Cinqaero, covering 2025-04-11 to 2025-04-11. Get the full timeline:
Most recent: EMA Authorised: Cinqaero (reslizumab) — Teva B.V.